We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Anticoagulation Reduces Stroke Risk of Cardioversion

By HospiMedica staff writers
Posted on 24 Oct 2002
In a large study, researchers found that if anticoagulation medication is given to patients with atrial fibrillation prior to cardioversion, the rate of stroke or other embolic happenings was less than 1%.

The study involved 717 patients with atrial fibrillation who had direct current (DC) cardioversion to electronically restore the heart's normal rhythm. More...
Prior to the procedure, all patients were administered anticoagulation medication. The results showed that the medication can greatly minimize the risk of stroke. In the United States alone, the researchers say atrial fibrillation is responsible for more than 70,000 strokes each year. The incidence of atrial fibrillation increases with age. The study was conducted by researchers at the Mayo Clinic (Rochester, MN, USA).

"If the decision favors cardioversion, the researchers have provided further proof of the efficacy of three to four weeks of warfarin anticoagulation before cardioversion,” write doctors from Beth Israel Deaconess Medical Center in Boston (MA, USA) in an accompanying editorial.




Related Links:
Mayo Clinic

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Pressure Guidewire
SavvyWire
Endoscopy Display
E190
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.